REGULATED PRESS RELEASE
News
-
-
-
-
PRESS RELEASE
Klea Holding améliore fortement ses résultats semestriels et confirme ses objectifs grâce à des tendances d'activité très favorables
Klea Holding affiche une croissance record de +46% de son chiffre d'affaires semestriel et une hausse spectaculaire de +118% de l'EBITDA normalisé pour le 1er semestre 2025. Désendettement significatif et retour aux actionnaires -
PRESS RELEASE
Klea Holding significantly improves its half-year results and confirms its targets thanks to very positive business trends
Klea Holding (ALKLH) reports impressive financial results for H1 2025 with +46% growth in revenue and normalised EBITDA up by +118%. Strategic objectives include debt reduction and shareholder returns -
PRESS RELEASE
Avec la certification de 3 nouveaux sites en France et en Allemagne, Lhyfe devient le plus grand producteur d'hydrogène RFNBO d'Europe par électrolyse de l'eau
Lhyfe certifie ses 4 premiers sites en Europe pour produire de l'hydrogène vert RFNBO, renforçant sa position de leader. Capacité totale de 21 MW. Maillage territorial unique -
PRESS RELEASE
With the certification of three new sites in France and Germany, Lhyfe becomes Europe's largest producer of RFNBO hydrogen from the electrolysis of water
Lhyfe becomes Europe's leading RFNBO hydrogen producer with 4 certified sites totaling 21MW capacity. Regional coverage, traceability, and sustainability highlighted -
-
PRESS RELEASE
CROSSJECT Secures Additional BARDA Funding for the Progressive Developmental and FDA Authorization of the ZEPIZURE® (ZENEO® Midazolam)
CROSSJECT secures $11.3 million BARDA funding for ZEPIZURE® development towards FDA authorization. Advances include validation batches and facility audit completion -
